Saba Capital Management Amends Filing for Morgan Stanley India Investment Fund
Ticker: IIF · Form: SC 13D/A · Filed: Oct 30, 2024 · CIK: 916618
| Field | Detail |
|---|---|
| Company | Morgan Stanley India Investment Fund, Inc. (IIF) |
| Form Type | SC 13D/A |
| Filed Date | Oct 30, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $19,225,672 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, amendment
TL;DR
Saba Capital updated its 13D filing for MS India Fund. Watch for potential strategy changes.
AI Summary
Saba Capital Management, L.P. has filed an amendment (No. 2) to its Schedule 13D/A regarding Morgan Stanley India Investment Fund, Inc. The filing, dated October 30, 2024, indicates a change in the reporting of beneficial ownership. Saba Capital Management, L.P. is listed as the filer, with its principal business address in New York, NY.
Why It Matters
This amendment signals a potential shift in the ownership structure or strategy concerning Morgan Stanley India Investment Fund, Inc., which could impact its market performance and investor relations.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in a significant shareholder's intentions or holdings, which can introduce uncertainty and potential volatility.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filer of the Schedule 13D/A
- Morgan Stanley India Investment Fund, Inc. (company) — Subject company
- 20241030 (date) — Date of filing
FAQ
What is the specific nature of the amendment (No. 2) to the Schedule 13D/A?
The filing is an amendment (No. 2) to the Schedule 13D/A, indicating a change in the previously reported information regarding beneficial ownership of Morgan Stanley India Investment Fund, Inc. by Saba Capital Management, L.P.
Who is the subject company in this filing?
The subject company is Morgan Stanley India Investment Fund, Inc.
Who is the entity filing the Schedule 13D/A amendment?
Saba Capital Management, L.P. is the entity filing the Schedule 13D/A amendment.
What is the filing date of this amendment?
The filing date of this amendment is October 30, 2024.
What is the business address of the filer?
The business address of Saba Capital Management, L.P. is 405 Lexington Avenue, 58th Floor, New York, NY 10174.
Filing Stats: 1,317 words · 5 min read · ~4 pages · Grade level 11.6 · Accepted 2024-10-30 14:50:36
Key Financial Figures
- $0.01 — INC. (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
- $19,225,672 — ported herein. A total of approximately $19,225,672 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 66KB
- 0001062993-24-018109.txt ( ) — 68KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 30, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 61745C105 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 9/5/2024 Buy 28,978 27.96 9/10/2024 Buy 6,336 27.99 9/13/2024 Buy 2,200 28.46 9/26/2024 Buy 20,224 30.25 9/27/2024 Buy 7,996 30.32 10/23/2024 Buy 7,615 27.65 10/24/2024 Buy 200 27.59 10/29/2024 Buy 19,759 27.68